Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
This voter-approved investor backed Zhou B Arts, KD Academy and a new hotel at 18th and Vine; now it has a new home
EDCKC absorbing initiative built to strengthen KC’s urban core after $60M in investments A move to transition the Central City Economic Development (CCED) program under the umbrella of a larger KCMO impact agency is expected to boost the urban core-focused initiative’s ability to uplift both the people and the places at the heart of Kansas…
Hidden costs of grief: Chef’s murder illustrates economic toll of gun violence in KC
Editor’s note: This story was originally published by The Beacon, a member of the KC Media Collective, which also includes Startland News, KCUR 89.3, American Public Square, Kansas City PBS/Flatland, and Missouri Business Alert. Click here to read the original story from The Beacon, an online news outlet focused on local, in-depth journalism in the public interest.…
‘The American dream is the Midwest’: LaunchKC powers next generation of startup job creators
Editor’s note: The following is part of an ongoing feature series exploring impacts of initiatives within the Economic Development Corporation of Kansas City through a paid partnership with EDCKC. Relocating to Kansas City after winning a LaunchKC grant — and the community and infrastructure support that comes with it — gives Russel Karim’s startup a centralized…
Roz audits its path to $2.15M in early funding; how KC helped this AI startup scale its potential
A series of funding wins is boosting a Kansas City startup’s efforts to automate the most complex — and tedious — parts of compliance work, drawing from the co-founder’s own pain points and resources from a server-full of local entrepreneur support initiatives. With $2.15 million in funding under its belt so far, Olathe-based Roz — which…